WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Mohammad Mokhber: Who is Iran’s acting president?
Italian region to halt COVID testing upon arrival from China
Ambitious Ivankovic aims for World Cup finals
Devout Christian doctor, 68, who punched dementia
Chinese state councilor calls for strenuous efforts in final preparations for Paris Olympics
Real Madrid complaint says ref 'negligent' on Vinicius abuse
British gymnast Ondine Achampong suffers ACL tear ahead of Paris Olympics
Red Lobster seeks bankruptcy protection after closing some restaurants
2 Ukrainians were stabbed in Germany. Prosecutors are examining a possible political motive